See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2017_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 22,708,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 763,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 10,624,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,271,754 |
| 9 | ResearchAndDevelopmentExpense | 43,032,557 |
| 10 | remainder_Expenses | -2,056,851 |
| 11 | remainder_Revenues | 2,805,651 |
| 12 | remainder_NetIncome | 1,774,318 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,471,000 |
| 1 | Liabilities | 10,624,000 |
| 2 | Expenses | 52,247,460 |
| 3 | Revenues | 2,805,651 |
| 4 | StockholdersEquity | 12,847,000 |
| 5 | NetIncome | -47,667,491 |
| 6 | ComprehensiveNetIncome | -47,667,491 |
| 7 | BaseVar | 45,461,214 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.15 |
| 9 | EconomicCapitalRatio | 1.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
